Asuncion Albert-Mari
Overview
Explore the profile of Asuncion Albert-Mari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
17
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chovi-Trull M, Ballesta-Lopez O, Navarro Buendia G, Sivera-Mascaro R, Albert-Mari A, Ruiz Caldes M, et al.
Eur J Hosp Pharm
. 2024 Aug;
PMID: 39174292
A 53-year-old male with recovering alcohol dependency, diagnosed with bipolar disorder and recurrent episodes of diverticulitis, came to the emergency department with disorientation and confusion after 3 days of treatment...
2.
Albert-Mari A, Jimenez-Pulido I, San Jose-Ruiz B, Conde-Estevez D, Gil-Lemus M, Cercos-Lleti A, et al.
J Oncol Pharm Pract
. 2022 Apr;
28(5):1170-1181.
PMID: 35469494
No abstract available.
3.
Albert-Mari A, Gil-Lemus M, Conde-Estevez D, San Jose-Ruiz B, Jimenez-Pulido I, Esteban-Mensua M, et al.
Farm Hosp
. 2021 Jul;
45(4):198-203.
PMID: 34218766
Objective: To reach at an expert consensus, using the Delphi method, for classifying the tissue-damaging potential of antineoplastic drugs, in order to facilitate the decision-making process in the event of ...
4.
Ballesta-Lopez O, Albert-Mari A, Borrell-Garcia C, Melian-Sosa M, Salvador-Coloma C, Santaballa-Bertran A, et al.
J Oncol Pharm Pract
. 2020 Apr;
27(2):268-278.
PMID: 32279599
Purpose: Intraperitoneal with intravenous chemotherapy (IP/IV) is the recommended option for patients with stage III cancer with optimally debulked (<1 cm residual) disease based on randomized controlled trials and showing...
5.
Sendra-Garcia A, Martinez-Gomez M, Albert-Mari A, Jimenez-Torres N, Climente-Marti M
J Oncol Pharm Pract
. 2019 Mar;
25(5):1204-1216.
PMID: 30895861
This article compares gravimetry vs. high-performance liquid chromatography (HPLC) as quality control (QC) methods for paclitaxel, docetaxel and oxaliplatin preparations. We aimed at assessing the preparation method reliability in our...
6.
Perez-Huertas P, Cueto-Sola M, Escobar-Cava P, Fernandez-Navarro J, Borrell-Garcia C, Albert-Mari A, et al.
J Pediatr Oncol Nurs
. 2016 Feb;
34(1):13-19.
PMID: 26902502
Objective: To study the incidence, risk factors, and treatment of hemorrhagic cystitis secondary to BK-virus reactivation (HC-BKV) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in the pediatric population. Methods: Case-control...
7.
Ruiz-Millo O, Albert-Mari A, Sendra-Garcia A, Jimenez-Torres N
J Oncol Pharm Pract
. 2013 Nov;
20(5):341-50.
PMID: 24177355
Purpose: To evaluate the cost-effectiveness of the addition of bevacizumab to the irinotecan-fluorouracil (Douillard regimen-CPT-FUFA-) in first-line treatment of metastatic colorectal cancer in a single-institution population. Methods: Controlled, nonrandomized retrospective...
8.
Serrano-Fabia A, Albert-Mari A, Almenar-Cubells D, Jimenez-Torres N
J Oncol Pharm Pract
. 2009 Jul;
16(2):105-12.
PMID: 19617304
Objective: To analyze medication errors (MEs) in a multidisciplinary system with a Computerized Pharmacotherapy Process (CPP) in cancer patients. Design: A longitudinal, prospective 2-year (January 2003 -to December 2004) cohort...